A new study published in the American Journal of Physiology – Endocrinology and Metabolism (ANI) reveals that a hormone blocker could help to achieve weight loss, improve levels of insulin resistance and perhaps even reverse diabetes .
GIP (Gastric Inhibitory Polypeptide) is one type of peptide hormone that secretes in response to eating food . It is also involved in the release of insulin as part of the digestive process, and therefore plays a role in metabolising fat .
The research team studies an eight week old male mice model, with obesity problems similar to that found in humans. The mice were divided and fed on different diets, one containing GIP.
Those fed GIP were able to counter many of the usual problems associated with eating a high fat diet . In the future, this discovery could alter how diabetes is treated and influence the way in which obesity and metabolic disorders are handled.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…